根治性盆腔放疗与新诊断转移性宫颈癌患者生存的关联
Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer.
PubMed 文献 · JAMA Oncol · 2018-01-01
该队列研究比较了新诊断转移性宫颈癌患者单纯化疗与化疗联合盆腔放疗的总生存。原文未报告具体样本量、生存数据或统计结果。
要点
- 比较新诊断转移性宫颈癌单纯化疗与化疗联合盆腔放疗的总生存
- 研究设计为队列研究
- 具体疗效数据需参见原文全文
核心结论
- 研究探讨根治性盆腔放疗是否与新诊断转移性宫颈癌患者总生存相关。
研究设计与样本
- 队列研究,比较新诊断转移性宫颈癌患者接受单纯化疗与化疗联合盆腔放疗的总生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This cohort study investigates overall survival among patients with newly diagnosed metastatic cervical cancer who received chemotherapy alone compared with those who received chemotherapy and pelvic radiation therapy.
来源:JAMA Oncol,查看原文。版权归原作者所有。
引用
- Wang Y, Farmer M, Izaguirre EW, et al. Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer. JAMA Oncol. 2018. PMID: 30054609. doi:10.1001/jamaoncol.2018.2677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。